<DOC>
	<DOCNO>NCT02667054</DOCNO>
	<brief_summary>To determine RX0041-002 safe effective topical anesthetic .</brief_summary>
	<brief_title>Topical Anesthetic Procedures Through Nose</brief_title>
	<detailed_description>This phase III single-dose , randomize , placebo dose-controlled study evaluate safety efficacy RX0041-002 topical solution local anesthesia diagnostic procedure surgeries mucous membrane nasal cavity ( e.g . nasal/sinus endoscopy , sinusotomy , fracture nasal turbunate ( ) , lysis intranasal synechia , insertion nasal septal prosthesis , biopsy intranasal , excision nasal polyp , excision turbinate ( ) , removal foreign body intranasal , septoplasty , sinus debridement ) .</detailed_description>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<criteria>1 . Is able understand comply protocol requirement , provide write informed consent HIPPA authorization . Residents California must also review sign California Subject Bill Rights . 2 . Is male female ≥18 year age , inclusive , time dose . 3 . Has predetermine need physician diagnostic procedure surgery nasal mucous membrane either one nostril . 4 . Has ability feel pain sensation normally anterior nasal septum , verify Von Frey 6.10 filament test . 5 . Has ability clearly communicate pain sensation anterior nasal septum . 6 . Females ( childbearing potential sexually active ) male ( sexually active partner childbearing potential ) agree use medically acceptable effective birth control method first dose 8 day follow last dose study drug . Medically acceptable method contraception may use participant and/or his/her partner include abstinence , birth control pills patch , diaphragm , intrauterine device ( IUD ) , condom , surgical sterilization , progestin implant injection . Prohibited method include : rhythm method withdrawal . 1 . Has know allergy ester base anesthetic include cocaine HCl , procaine , tetracaine , chloroprocaine , dibucaine , benzocaine , and/or compound drug /or device part protocol . ( Amide base anesthetic allergy NOT exclusionary . Amide base anesthetic : Lidocaine , Mepivicaine , Bupivicaine , Levobupivicaine , Ropivicaine , Etidocaine , Prilocaine , Articaine ) . 2 . Is &lt; Less 18 year age . 3 . Has previously receive study drug study . 4 . Has history abuse control substance , nasal otherwise , damage nasal space , opinion investigator might interfere ability subject investigator judge analgesia study drug . 5 . Has participate investigational study receive investigational drug within 30 day precede randomization . 6 . Is pregnant nursing mother . 7 . Women childbearing potential ( WOCBP ) men must use acceptable method contraception avoid pregnancy throughout study , woman 30 day men 90 day last dose investigational product manner risk pregnancy risk pregnancy minimize . 8 . Suffers condition , need diagnostic procedure surgery nasal mucous membrane , opinion Investigator , would compromise safety subject , quality data , normal wound heal process . 9 . Has severely traumatize mucosa sepsis nasal cavity . 10 . Subjects experienced seizure take isoniazid ( INH ) , phenothiazine , chlorpromazine , thioridazine , theophylline , tricyclic antidepressant amitriptyline . 11 . Use analgesic 2 day prior screen need use drug screen period throughout time period trial . This include NSAIDs ibuprofen , diclofenac , indomethacin , sulindac , tolmetin , ketoprofen , flurbiprofen , naprozen , opioids codeine , hydrocodone , hydromorphone , morphine , oxycodone aspirin , acetaminophen . 12 . Use SNRIs/SSRIs to7 day prior screen need use drug screen period throughout time period trial . 13 . Use MAO Inhibitor drug to14 day prior screen need use drug screen period throughout time period trial . 14 . Subjects experienced seizure take isoniazid ( INH ) , phenothiazine , chlorpromazine , thioridazine , theophylline , tricyclic antidepressant amitriptyline . Has history seizure , exception febrile seizure . 15 . Has history myocardial infarction , coronary artery disease , congestive heart failure , irregular heart rhythm , uncontrolled hypertension ( defined average SBP ≥140 mmHg average DBP ≥90 mmHg ) take monoamine oxidase inhibitor . Uncontrolled hypertension define systolic blood pressure great equal 140 mm Hg diastolic blood pressure great equal 90 mm Hg . 16 . Has know personal family history hereditary pseudocholinesterase deficiency . Study participant screen ask personal family history anesthetic reaction , anesthetic death , previous diagnosis psuedochloinesterase deficiency relative personally . Subjects identify pseudocholinesterase deficiency risk delay recovery certain anesthetic ( e.g . succinylcholine esterbased anesthetic ) . 17 . Has know personal family history pheochromocytoma . Study participant specifically ask treated pheochromocytoma previously family member diagnose pheochromocytoma ( since 10 % familial ) . 18 . Has know personal family history adrenal tumor . 19 . Has use amphetamine , stimulant prescription nonprescription product catecholamine ( direct indirect act sympathomimetics ) , bronchial inhaler contain sympathomimetics ( epinephrine betareceptor agonist ) herbal product 2 day prior screen need use drug course study . 20 . Has screen 12lead ECG finding abnormality . Generally , current prior myocardial ischemia infarction , dysrhythmia , risk serious dysrhythmia ( prolonged QT interval ) . An exception would sinus bradycardia sinus tachycardia present , Investigator must determine whether find clinically relevant exclusionary 21 . Has positive urine pregnancy test Screening Day 1 . 22 . Has positive urine test result drug abuse ( amphetamine , barbiturate , cannabinoids , cocaine metabolite , opiates oxycodone ) Screening Day 1 . 23 . Hemoglobin &lt; 8.5 g/dl ; onetime retest allow Hb 8.38.4 g/dl . 24 . WBC &lt; 3.5 x 103 cells/mcl ; onetime retest allow WBC 3.33.4 x 103 cells/mcl . 25 . Platelets &lt; 100 x 103 platelets/mcl ; onetime retest allow platelet 9099 x 103 platelets/mcl . 26 . Serum Potassium &lt; 3.5 &gt; 4.5 mEq/L . 27 . Serum ALT , AST , bilirubin exceed 2X ULN lab 's reference value . 28 . Is suitable entry study opinion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>